DSP variants in ARVC cohorts


The table below lists the 43 rare (MAF<0.0001 in ExAC) protein-altering DSP variants identified in a cohort of 352 ARVC patients. When this rare variant frequency of 0.12216 is compared with a background population rate of 0.03148, there is a statistically significant case excess of 0.09068 (p<0.0001), which suggests that approximately 32 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      OMGL



No. Variant (CDS) Variant (Protein) Variant Type Cases (352)OMGL class ExAC frequency
1. c.4868C>G p.S1623Cmissense 1VUS0.000000
2. c.1759T>A p.Y587Nmissense 1VUS0.000000
3. c.1103T>C p.I368Tmissense 1VUS0.000074
4. c.2609T>C p.I870Tmissense 1VUS0.000008
5. c.1445G>A p.C482Ymissense 1VUS0.000000
6. c.8390T>C p.I2797Tmissense 1VUS0.000032
7. c.4117A>G p.T1373Amissense 1VUS0.000091
8. c.6181C>T p.P2061Smissense 1VUS0.000000
9. c.1325C>T p.S442Fmissense 1VUS0.000000
10. c.8120T>C p.M2707Tmissense 1VUS0.000008
11. c.944G>C p.R315Pmissense 1VUS0.000000
12. c.7784C>T p.T2595Imissense 1VUS0.000008
13. c.2799G>C p.L933Fmissense 1VUS0.000075
14. c.4996C>T p.R1666Wmissense 1VUS0.000066
15. c.7012G>A p.G2338Rmissense 1VUS0.000000
16. c.1352G>A p.R451Hmissense 1VUS0.000000
17. c.943C>T p.R315Cmissense 1VUS0.000074
18. c.8309A>G p.Y2770Cmissense 1VUS0.000033
19. c.3764G>A p.R1255Kmissense 1VUS0.000033
20. c.2161G>A p.E721Kmissense 1Likely Pathogenic0.000000
21. c.7940G>A p.G2647Dmissense 1VUS0.000008
22. c.3562T>C p.Y1188Hmissense 1VUS0.000067
23. c.6496C>T p.R2166Xnonsense 1Pathogenic0.000000
24. c.4477G>T p.E1493Xnonsense 1Pathogenic0.000000
25. c.3195C>G p.Y1065Xnonsense 1Likely Pathogenic0.000000
26. c.478C>T p.R160Xnonsense 1Pathogenic0.000000
27. c.2046C>A p.C682Xnonsense 1Likely Pathogenic0.000000
28. c.4501G>T p.E1501Xnonsense 1Pathogenic0.000000
29. c.3133C>T p.R1045Xnonsense 1Pathogenic0.000000
30. c.415C>T p.Q139Xnonsense 1Pathogenic0.000000
31. c.1288G>T p.E430Xnonsense 2Pathogenic0.000000
32. c.2130+1G>C essential splice site 1Pathogenic0.000000
33. c.818dup p.Asn274Glufs*15frameshift 1Pathogenic0.000000
34. c.8077_8080del p.Lys2693Profs*3frameshift 1Likely Pathogenic0.000000
35. c.1188_1195dup p.Ile399Argfs*44frameshift 1Pathogenic0.000000
36. c.3735_3741dup p.Asp1248Lysfs*7frameshift 1Pathogenic0.000000
37. c.5659_5660del p.Lys1887Glufs*2frameshift 1Pathogenic0.000000
38. c.1124dup p.Asn375Lysfs*9frameshift 1Pathogenic0.000000
39. c.1755dup p.His586Thrfs*9frameshift 1Pathogenic0.000000
40. c.3329del p.Lys1110Argfs*5frameshift 1Pathogenic0.000000
41. c.1068dup p.Gln357Alafs*13frameshift 1Pathogenic0.000000
42. c.6118_6121del p.Ile2040Alafs*18frameshift 1Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.